(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

DERMALIGHT

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

DERMALIGHT

ST13

US500000090261662

Class

5

Filing

90261662

Registration

6675066

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

18

Latest update

03/22/2022

Trademark type

Combined

Nice classes

5

Filing date

10/18/2020

Registration date

03/22/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/22/2022

Last transaction

03/22/2022

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use, Foreign priority

Drawing code

5

Owner type

99

Owner location

Tosu-shi, Saga, JP

Examiner

CASE, LEIGH CAROLINE

Law office

M30

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the word "DermaLight" in stylized font.

Holders and representatives

Holders

HISAMITSU PHARMACEUTICAL CO., INC.

Representatives

Scott S. Havlick HOLLAND & HART LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Medicated transdermal patchesplasterspadscataplasmsgelssprays for relief of the aches of rheumatoid arthritisthe aches and pains of musclesjoints and tendons; anti-inflammatory and analgesic agents; pharmaceutical preparations for the relief of pain; adhesive plasters for medical purposes; bandages for dressings; dietary supplements for humans; Medicated transdermal patches for use in treatment of pain relief; medicated transdermal patches with micro needles for use in treatment of pain relief

Publications

History of USPTO decisions and trademark events.

18 publications found

R.PR

REGISTERED-PRINCIPAL REGISTER

03/22/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

01/04/2022

PUBO

PUBLISHED FOR OPPOSITION

01/04/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/15/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/02/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/30/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/30/2021

ALIE

ASSIGNED TO LIE

11/29/2021

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

11/23/2021

GNS2

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

07/08/2021

GNSI

INQUIRY TO SUSPENSION E-MAILED

07/08/2021

CNSI

SUSPENSION INQUIRY WRITTEN

07/08/2021

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

12/16/2020

GNSL

LETTER OF SUSPENSION E-MAILED

12/16/2020

CNSL

SUSPENSION LETTER WRITTEN

12/16/2020

DOCK

ASSIGNED TO EXAMINER

12/09/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/05/2020

NWAP

NEW APPLICATION ENTERED

10/21/2020

Continuous trademark protection

Get notified about every new filing that threatens DERMALIGHT or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.